Skip to main content
. Author manuscript; available in PMC: 2010 Feb 1.
Published in final edited form as: Neuropsychopharmacology. 2009 Apr 22;34(9):2143–2155. doi: 10.1038/npp.2009.40

Fig. 2.

Fig. 2

Effects of modulating PKA activity on 5CSRTT performance. (A) Sp-cAMPS (2.1 nmol) did not affect accuracy (mean ± SEM) but (B) increased omissions. (C) Rp-cAMPS (21.0 nmol) impaired accuracy and (D) increased omissions. Dotted line (A, C) represents performance following vehicle (0.0 nmol) infusions. **P<0.01 compared to vehicle, Fisher’s protected t-tests.